CDKN2B and cancer: CDKN2B, also known as P15, belongs to the INK4 family, which has been identified as an inhibitor of cyclin-dependent kinase 4, thus inhibiting cell cycle progression and facilitating cell apoptosis in a variety of human cancers (26, 27).